Company Filing History:
Years Active: 2017-2020
Title: Fiona Karen Harlan: Innovator in Therapeutic Compounds
Introduction
Fiona Karen Harlan is a distinguished inventor based in Eugene, OR (US). She has made significant contributions to the field of therapeutic compounds, holding a total of 5 patents. Her work focuses on the development of innovative solutions for targeting specific subcellular areas in the treatment of diseases.
Latest Patents
Among her latest patents is the invention of targeted peptide conjugates. This invention relates to the preparation and use of therapeutic compounds designed for the treatment of diseases at specific subcellular target areas, such as cellular organelles. The compounds aim to modify enzyme activity within targeted organelles or structures, including lysosomes, autophagasomes, the endoplasmic reticulum, the Golgi complex, peroxisomes, the nucleus, membranes, and mitochondria. Another notable patent is for intracellular organelle peptide targeted enzyme substrates. This invention involves substrates and methods for visualizing intracellular organelles based on organelle enzyme activity. The compounds are designed to provide high fluorescence at lower pH values found in certain organelles, enabling monitoring of enzyme activity inside cells at very low concentrations.
Career Highlights
Fiona is currently associated with Marker Gene Technologies, Inc., where she continues to advance her research and innovations. Her work has positioned her as a key figure in the development of therapeutic strategies that leverage the specificity of peptide conjugates.
Collaborations
Fiona has collaborated with notable colleagues, including John Joseph Naleway and Jason Scott Lusk. These collaborations have further enriched her research and contributed to the success of her inventions.
Conclusion
Fiona Karen Harlan is a pioneering inventor whose work in therapeutic compounds is making a significant impact in the medical field. Her innovative patents reflect her commitment to advancing science and improving treatment methodologies.